Evaluation of AAV-mediated delivery of shRNA to target basal-like breast cancer genetic vulnerabilities.
Pinto C, Silva G, Ribeiro AS, Oliveira M, Garrido M, Bandeira VS, Nascimento A, Coroadinha AS, Peixoto C, Barbas A, Paredes J, Brito C, Alves PM.
Pinto C, et al. Among authors: nascimento a.
J Biotechnol. 2019 Jul 20;300:70-77. doi: 10.1016/j.jbiotec.2019.05.016. Epub 2019 May 28.
J Biotechnol. 2019.
PMID: 31150679